Oncology Clinical Trial
Official title:
Psychological Distress in Outpatient Oncological Rehabilitation
The aim of the study is to assess psychological distress and co-morbidity as well as relevant sociodemographic, anthropometric, medical and functional data in patients treated at the Outpatient Clinic for Oncological Rehabilitation at the Department of Physical Medicine, Rehabilitation and Occupational Medicine at the Medical University of Vienna.
Psychological distress in cancer patients is higher than in the average population and is
associated with a lower health-related quality of life. In the course of the disease and its
treatment, a psychological distress reaction can lead to a psychosocial crisis and a mental
disorder that requires treatment. On average, 25% of all cancer patients suffer from
depression, anxiety or adjustment disorders at any point in the course of their disease, and
an average of 32% of all cancer patients express the need for psychosocial support. With an
increasing reduction in inpatient length of stay times, outpatient care gains growing
importance in the context of psycho-oncological diagnostics and aftercare. The overlap
between physical symptoms due to cancer diagnosis and treatment and physical symptoms that
are related to psychological burdens requires sensitive psycho-oncological diagnostics. This
should be carried out as early as possible in the course of the disease so that existing
psychological distress can be recognized early and thus a progression of the symptoms can be
prevented.
The study aims to assess psychological distress and co-morbidity as well as relevant
sociodemographic, anthropometric, medical and functional data in patients treated at the
Outpatient Clinic for Oncological Rehabilitation at the Department of Physical Medicine,
Rehabilitation and Occupational Medicine at the Medical University of Vienna.
Results should serve as a basis for further individual treatment recommendations.
By ascertaining the psychological distress, appropriate support and treatment measures can be
recommended to the patients at an early stage, which help to improve the symptoms, enable
participation and thus improve the quality of life of the patients. The assessment of the
current individual need for psychological care also helps to refer patients to an inpatient
oncological rehabilitation setting that provides the care that is needed more appropriately.
Results should also improve the psychological care of oncologic patients in general. Based on
the findings, the psychological care offered within the framework of the current outpatient
and inpatient oncological rehabilitation setting could be adapted and expanded as necessary.
The results of the study should serve to integrate psycho-oncological care into the overall
outpatient oncological rehabilitation concept.
A monocentric cross-sectional study is to be carried out on 165 patients with malignant
tumour diseases as well as benign central nervous system tumours over a period of
approximately 2 years.
Medical assessment of sociodemographic, anthropometric, medical and functional data will be
performed. The gained information is also relevant for physical therapy prescription and
treatment recommendations given by the physiatrist at the outpatient clinic for oncological
rehabilitation.
Psychological distress and the need for psycho-oncological care for outpatients is determined
through standardized screening and suitable assessment procedures. Patients will receive an
immediate therapy recommendation regarding their psychological complaints by the clinical
psychologist and psychotherapist who performs the assessment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01439152 -
Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.
|
Phase 1 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Active, not recruiting |
NCT06015009 -
Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers
|
N/A | |
Active, not recruiting |
NCT03298100 -
Risk Scoring Model for Endometrial Cancer
|
||
Recruiting |
NCT05055609 -
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
|
Phase 1 | |
Completed |
NCT00588289 -
Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA
|
N/A | |
Recruiting |
NCT06222801 -
The 1st Tumor CytokinoTherapy Database (TCTD-1)
|
||
Recruiting |
NCT03831633 -
Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
|
Phase 4 | |
Completed |
NCT04914702 -
Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
|
||
Recruiting |
NCT05198570 -
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
|
||
Recruiting |
NCT05712174 -
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT03832062 -
Value of Analysing Under-utilised Leftover Tissue (VauLT)
|
||
Completed |
NCT03988777 -
Magnetic Seed Localisation for Nonpalpable Breast Lesions
|
||
Recruiting |
NCT06031233 -
Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
|
Phase 4 | |
Enrolling by invitation |
NCT04019119 -
Digital Intervention for the Modification of Lifestyles (iGame)
|
N/A | |
Not yet recruiting |
NCT05926362 -
Capillary-Venous Paired Data Collection
|
||
Recruiting |
NCT05686213 -
ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial
|
Phase 2 | |
Recruiting |
NCT05510856 -
Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients
|
Phase 4 | |
Completed |
NCT04180306 -
PEWS Implementation in an LMIC Setting
|
N/A | |
Completed |
NCT04933604 -
LPN in Patients With High-complex Renal Tumors
|